November 17, 2026 · Menopause (New York, N.Y.) · DOI: 10.1097/GME.0000000000002953

Updated clinical recommendations for cardiovascular risk assessment to facilitate hormone therapy prescribing: incorporating PREVENT risk calculator and the 2026 multisociety lipid guidelines.

Listen to this summary

This perspective asks how clinicians can integrate cardiovascular risk assessment, using the newly introduced PREVENT calculator and the 2026 multisociety lipid guideline, into decisions about menopausal hormone therapy (HT). The authors propose a practical framework that stratifies women by PREVENT-derived 10- and 30-year risk, incorporates coronary artery calcium scoring and female-specific risk enhancers, and aligns lipid management targets with HT initiation and route of administration. Their goal is to help clinicians individualize HT decisions for symptomatic midlife women while optimizing cardiovascular risk reduction.

Chrisandra L Shufelt, Cynthia A Stuenkel, Emily S Lau, JoAnn E Manson, Stephanie S Faubion

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play